位置:首页 > 蛋白库 > KEFC_ECOLI
KEFC_ECOLI
ID   KEFC_ECOLI              Reviewed;         620 AA.
AC   P03819;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1991, sequence version 2.
DT   03-AUG-2022, entry version 195.
DE   RecName: Full=Glutathione-regulated potassium-efflux system protein KefC {ECO:0000255|HAMAP-Rule:MF_01413};
DE   AltName: Full=K(+)/H(+) antiporter {ECO:0000255|HAMAP-Rule:MF_01413};
GN   Name=kefC {ECO:0000255|HAMAP-Rule:MF_01413}; Synonyms=trkC;
GN   OrderedLocusNames=b0047, JW0046;
OS   Escherichia coli (strain K12).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND SUBCELLULAR LOCATION.
RC   STRAIN=K12 / CS520;
RX   PubMed=2046548; DOI=10.1111/j.1365-2958.1991.tb00731.x;
RA   Munro A.W., Ritchie G.Y., Lamb A.J., Douglas R.M., Booth I.R.;
RT   "The cloning and DNA sequence of the gene for the glutathione-regulated
RT   potassium-efflux system KefC of Escherichia coli.";
RL   Mol. Microbiol. 5:607-616(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12;
RX   PubMed=1630901; DOI=10.1093/nar/20.13.3305;
RA   Yura T., Mori H., Nagai H., Nagata T., Ishihama A., Fujita N., Isono K.,
RA   Mizobuchi K., Nakata A.;
RT   "Systematic sequencing of the Escherichia coli genome: analysis of the 0-
RT   2.4 min region.";
RL   Nucleic Acids Res. 20:3305-3308(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J., Mau B.,
RA   Shao Y.;
RT   "The complete genome sequence of Escherichia coli K-12.";
RL   Science 277:1453-1462(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   "Highly accurate genome sequences of Escherichia coli K-12 strains MG1655
RT   and W3110.";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 500-620.
RC   STRAIN=K12;
RX   PubMed=6159575; DOI=10.1093/nar/8.10.2255;
RA   Smith D.R., Calvo J.M.;
RT   "Nucleotide sequence of the E coli gene coding for dihydrofolate
RT   reductase.";
RL   Nucleic Acids Res. 8:2255-2274(1980).
RN   [6]
RP   SIMILARITY TO NAPA.
RX   PubMed=1325937; DOI=10.1016/0378-1097(92)90601-j;
RA   Reizer J., Reizer A., Saier M.H. Jr.;
RT   "The putative Na+/H+ antiporter (NapA) of Enterococcus hirae is homologous
RT   to the putative K+/H+ antiporter (KefC) of Escherichia coli.";
RL   FEMS Microbiol. Lett. 73:161-163(1992).
RN   [7]
RP   FUNCTION, AND ACTIVITY REGULATION.
RC   STRAIN=K12;
RX   PubMed=9023177; DOI=10.1128/jb.179.4.1007-1012.1997;
RA   Ferguson G.P., Nikolaev Y., McLaggan D., Maclean M., Booth I.R.;
RT   "Survival during exposure to the electrophilic reagent N-ethylmaleimide in
RT   Escherichia coli: role of KefB and KefC potassium channels.";
RL   J. Bacteriol. 179:1007-1012(1997).
RN   [8]
RP   TOPOLOGY [LARGE SCALE ANALYSIS], AND SUBCELLULAR LOCATION.
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=15919996; DOI=10.1126/science.1109730;
RA   Daley D.O., Rapp M., Granseth E., Melen K., Drew D., von Heijne G.;
RT   "Global topology analysis of the Escherichia coli inner membrane
RT   proteome.";
RL   Science 308:1321-1323(2005).
RN   [9]
RP   FUNCTION, ACTIVITY REGULATION, AND SUBUNIT.
RX   PubMed=17679694; DOI=10.1073/pnas.0703709104;
RA   Fujisawa M., Ito M., Krulwich T.A.;
RT   "Three two-component transporters with channel-like properties have
RT   monovalent cation/proton antiport activity.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:13289-13294(2007).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.40 ANGSTROMS) OF 401-620 IN COMPLEX WITH KEFF AND
RP   AMP, SUBUNIT, INTERACTION WITH KEFF, MUTAGENESIS OF ASP-264; ARG-416;
RP   GLU-520; ALA-522; GLY-526 AND ASN-551, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=19523906; DOI=10.1016/j.str.2009.03.018;
RA   Roosild T.P., Castronovo S., Miller S., Li C., Rasmussen T., Bartlett W.,
RA   Gunasekera B., Choe S., Booth I.R.;
RT   "KTN (RCK) domains regulate K+ channels and transporters by controlling the
RT   dimer-hinge conformation.";
RL   Structure 17:893-903(2009).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) OF 401-620 IN COMPLEXES WITH KEFF;
RP   AMP AND GLUTATHIONE, FUNCTION, SUBUNIT, INTERACTION WITH KEFF, ACTIVITY
RP   REGULATION, DOMAIN, AND MUTAGENESIS OF GLN-412; ARG-416; PHE-441; ASP-499;
RP   ARG-516 AND ASN-551.
RX   PubMed=21041667; DOI=10.1073/pnas.1012716107;
RA   Roosild T.P., Castronovo S., Healy J., Miller S., Pliotas C., Rasmussen T.,
RA   Bartlett W., Conway S.J., Booth I.R.;
RT   "Mechanism of ligand-gated potassium efflux in bacterial pathogens.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:19784-19789(2010).
CC   -!- FUNCTION: Pore-forming subunit of a potassium efflux system that
CC       confers protection against electrophiles. Catalyzes K(+)/H(+) antiport.
CC       Can also export rubidium, lithium and sodium. {ECO:0000255|HAMAP-
CC       Rule:MF_01413, ECO:0000269|PubMed:17679694,
CC       ECO:0000269|PubMed:21041667, ECO:0000269|PubMed:9023177}.
CC   -!- ACTIVITY REGULATION: Inhibited by glutathione. This inhibition is
CC       increased by NADH. Activated by adducts between glutathione and
CC       electrophiles. {ECO:0000269|PubMed:17679694,
CC       ECO:0000269|PubMed:21041667, ECO:0000269|PubMed:9023177}.
CC   -!- SUBUNIT: Homodimer. Interacts with the regulatory subunit KefF, forming
CC       a heterotetramer with 2:2 stoichiometry. Interaction with KefF is
CC       required for optimal activity. The active antiporter may be formed by
CC       the heterotetramer, or by an octamer. {ECO:0000255|HAMAP-Rule:MF_01413,
CC       ECO:0000269|PubMed:17679694, ECO:0000269|PubMed:19523906,
CC       ECO:0000269|PubMed:21041667}.
CC   -!- INTERACTION:
CC       P03819; P0A754: kefF; NbExp=2; IntAct=EBI-547193, EBI-562116;
CC   -!- SUBCELLULAR LOCATION: Cell inner membrane {ECO:0000255|HAMAP-
CC       Rule:MF_01413, ECO:0000269|PubMed:15919996,
CC       ECO:0000269|PubMed:2046548}; Multi-pass membrane protein
CC       {ECO:0000255|HAMAP-Rule:MF_01413, ECO:0000269|PubMed:15919996,
CC       ECO:0000269|PubMed:2046548}.
CC   -!- DOMAIN: The cytoplasmic RCK N-terminal domain regulates channel
CC       activity. It binds glutathione, resulting in inhibition of potassium
CC       efflux. In contrast, binding of the adducts formed between glutathione
CC       and electrophiles leads to activation of potassium efflux. Is expected
CC       to bind NADH, but X-ray crystallography shows bound AMP, and it would
CC       be difficult to accommodate NADH in this binding site
CC       (PubMed:21041667). {ECO:0000269|PubMed:21041667}.
CC   -!- SIMILARITY: Belongs to the monovalent cation:proton antiporter 2 (CPA2)
CC       transporter (TC 2.A.37) family. KefC subfamily. {ECO:0000255|HAMAP-
CC       Rule:MF_01413}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X56742; CAA40066.1; -; Genomic_DNA.
DR   EMBL; U00096; AAC73158.1; -; Genomic_DNA.
DR   EMBL; AP009048; BAB96615.1; -; Genomic_DNA.
DR   EMBL; J01609; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   PIR; S40568; QQECRD.
DR   RefSeq; NP_414589.1; NC_000913.3.
DR   RefSeq; WP_000377098.1; NZ_STEB01000010.1.
DR   PDB; 3EYW; X-ray; 2.40 A; A/B=401-620.
DR   PDB; 3L9W; X-ray; 1.75 A; A/B=401-620.
DR   PDB; 3L9X; X-ray; 2.10 A; A/B=401-620.
DR   PDBsum; 3EYW; -.
DR   PDBsum; 3L9W; -.
DR   PDBsum; 3L9X; -.
DR   AlphaFoldDB; P03819; -.
DR   SMR; P03819; -.
DR   BioGRID; 4262200; 8.
DR   ComplexPortal; CPX-2543; Glutathione-regulated potassium-efflux system KefC-KefF complex.
DR   DIP; DIP-10072N; -.
DR   IntAct; P03819; 3.
DR   STRING; 511145.b0047; -.
DR   TCDB; 2.A.37.1.1; the monovalent cation:proton antiporter-2 (cpa2) family.
DR   jPOST; P03819; -.
DR   PaxDb; P03819; -.
DR   PRIDE; P03819; -.
DR   EnsemblBacteria; AAC73158; AAC73158; b0047.
DR   EnsemblBacteria; BAB96615; BAB96615; BAB96615.
DR   GeneID; 944773; -.
DR   KEGG; ecj:JW0046; -.
DR   KEGG; eco:b0047; -.
DR   PATRIC; fig|1411691.4.peg.2236; -.
DR   EchoBASE; EB0516; -.
DR   eggNOG; COG0475; Bacteria.
DR   eggNOG; COG1226; Bacteria.
DR   HOGENOM; CLU_005126_9_3_6; -.
DR   InParanoid; P03819; -.
DR   OMA; PYLWFAK; -.
DR   PhylomeDB; P03819; -.
DR   BioCyc; EcoCyc:KEFC-MON; -.
DR   BioCyc; MetaCyc:KEFC-MON; -.
DR   EvolutionaryTrace; P03819; -.
DR   PRO; PR:P03819; -.
DR   Proteomes; UP000000318; Chromosome.
DR   Proteomes; UP000000625; Chromosome.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:EcoliWiki.
DR   GO; GO:0016020; C:membrane; IDA:EcoCyc.
DR   GO; GO:0005886; C:plasma membrane; IDA:EcoCyc.
DR   GO; GO:1903103; C:potassium:proton antiporter complex; IPI:ComplexPortal.
DR   GO; GO:0019899; F:enzyme binding; IMP:EcoCyc.
DR   GO; GO:0015503; F:glutathione-regulated potassium exporter activity; IMP:EcoCyc.
DR   GO; GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW.
DR   GO; GO:0015299; F:solute:proton antiporter activity; IEA:InterPro.
DR   GO; GO:0015643; F:toxic substance binding; IDA:EcoCyc.
DR   GO; GO:0051454; P:intracellular pH elevation; IC:ComplexPortal.
DR   GO; GO:0006813; P:potassium ion transport; IDA:EcoliWiki.
DR   GO; GO:0051453; P:regulation of intracellular pH; IC:ComplexPortal.
DR   GO; GO:0006885; P:regulation of pH; IDA:EcoliWiki.
DR   GO; GO:0051595; P:response to methylglyoxal; IMP:EcoCyc.
DR   GO; GO:0009636; P:response to toxic substance; IMP:EcoCyc.
DR   Gene3D; 1.20.1530.20; -; 1.
DR   HAMAP; MF_01413; K_H_efflux_KefC; 1.
DR   InterPro; IPR006153; Cation/H_exchanger.
DR   InterPro; IPR004771; K/H_exchanger.
DR   InterPro; IPR023941; K_H_efflux_KefC.
DR   InterPro; IPR006036; K_uptake_TrkA.
DR   InterPro; IPR038770; Na+/solute_symporter_sf.
DR   InterPro; IPR036291; NAD(P)-bd_dom_sf.
DR   InterPro; IPR003148; RCK_N.
DR   PANTHER; PTHR46157:SF3; PTHR46157:SF3; 1.
DR   Pfam; PF00999; Na_H_Exchanger; 1.
DR   Pfam; PF02254; TrkA_N; 1.
DR   PRINTS; PR00335; KUPTAKETRKA.
DR   SUPFAM; SSF51735; SSF51735; 1.
DR   TIGRFAMs; TIGR00932; 2a37; 1.
DR   PROSITE; PS51201; RCK_N; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Antiport; Cell inner membrane; Cell membrane; Ion transport;
KW   Membrane; Nucleotide-binding; Potassium; Potassium transport;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN           1..620
FT                   /note="Glutathione-regulated potassium-efflux system
FT                   protein KefC"
FT                   /id="PRO_0000196606"
FT   TOPO_DOM        1..3
FT                   /note="Periplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        4..24
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01413"
FT   TOPO_DOM        25
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        26..46
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01413"
FT   TOPO_DOM        47..53
FT                   /note="Periplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        54..74
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01413"
FT   TOPO_DOM        75..89
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        90..110
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01413"
FT   TOPO_DOM        111..113
FT                   /note="Periplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        114..134
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01413"
FT   TOPO_DOM        135..148
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        149..169
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01413"
FT   TOPO_DOM        170..177
FT                   /note="Periplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        178..198
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01413"
FT   TOPO_DOM        199..213
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        214..233
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01413"
FT   TOPO_DOM        234..236
FT                   /note="Periplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        237..254
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01413"
FT   TOPO_DOM        255..269
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        270..290
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01413"
FT   TOPO_DOM        291..293
FT                   /note="Periplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        294..314
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01413"
FT   TOPO_DOM        315..326
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        327..347
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01413"
FT   TOPO_DOM        348..358
FT                   /note="Periplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        359..379
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01413"
FT   TOPO_DOM        380..620
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305|PubMed:15919996"
FT   DOMAIN          401..523
FT                   /note="RCK N-terminal"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01413"
FT   REGION          259..267
FT                   /note="Important for the regulation of potassium
FT                   conductance"
FT   REGION          597..620
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         408..410
FT                   /ligand="AMP"
FT                   /ligand_id="ChEBI:CHEBI:456215"
FT                   /evidence="ECO:0000269|PubMed:19523906"
FT   BINDING         412
FT                   /ligand="glutathione"
FT                   /ligand_id="ChEBI:CHEBI:57925"
FT                   /ligand_note="ligand shared between dimeric partners"
FT   BINDING         429..430
FT                   /ligand="AMP"
FT                   /ligand_id="ChEBI:CHEBI:456215"
FT                   /evidence="ECO:0000269|PubMed:19523906"
FT   BINDING         434
FT                   /ligand="AMP"
FT                   /ligand_id="ChEBI:CHEBI:456215"
FT                   /evidence="ECO:0000269|PubMed:19523906"
FT   BINDING         449..450
FT                   /ligand="AMP"
FT                   /ligand_id="ChEBI:CHEBI:456215"
FT                   /evidence="ECO:0000269|PubMed:19523906"
FT   BINDING         472
FT                   /ligand="AMP"
FT                   /ligand_id="ChEBI:CHEBI:456215"
FT                   /evidence="ECO:0000269|PubMed:19523906"
FT   BINDING         496
FT                   /ligand="AMP"
FT                   /ligand_id="ChEBI:CHEBI:456215"
FT                   /evidence="ECO:0000269|PubMed:19523906"
FT   BINDING         498..500
FT                   /ligand="glutathione"
FT                   /ligand_id="ChEBI:CHEBI:57925"
FT                   /ligand_note="ligand shared between dimeric partners"
FT                   /note="in other chain"
FT   BINDING         516
FT                   /ligand="glutathione"
FT                   /ligand_id="ChEBI:CHEBI:57925"
FT                   /ligand_note="ligand shared between dimeric partners"
FT                   /note="in other chain"
FT   MUTAGEN         262
FT                   /note="E->K: Increases potassium efflux in the absence of
FT                   glutathione, but not in the presence of glutathione.
FT                   Increases constitutive potassium efflux; when associated
FT                   with D-551."
FT   MUTAGEN         264
FT                   /note="D->A: Increases constitutive potassium efflux."
FT                   /evidence="ECO:0000269|PubMed:19523906"
FT   MUTAGEN         412
FT                   /note="Q->A: Increases constitutive potassium efflux and
FT                   reduces glutathione-mediated inhibition of potassium
FT                   efflux."
FT                   /evidence="ECO:0000269|PubMed:21041667"
FT   MUTAGEN         412
FT                   /note="Q->K: Increases constitutive potassium efflux and
FT                   abolishes regulation of potassium efflux by glutathione and
FT                   glutathione adducts."
FT                   /evidence="ECO:0000269|PubMed:21041667"
FT   MUTAGEN         416
FT                   /note="R->A: Increases constitutive potassium efflux and
FT                   abolishes regulation of potassium efflux by glutathione and
FT                   glutathione adducts; when associated with A-516 and A-551."
FT                   /evidence="ECO:0000269|PubMed:19523906,
FT                   ECO:0000269|PubMed:21041667"
FT   MUTAGEN         416
FT                   /note="R->S: Increased constitutive potassium efflux."
FT                   /evidence="ECO:0000269|PubMed:19523906,
FT                   ECO:0000269|PubMed:21041667"
FT   MUTAGEN         441
FT                   /note="F->D,L: Reduced activation of potassium efflux by
FT                   glutathione adducts."
FT                   /evidence="ECO:0000269|PubMed:21041667"
FT   MUTAGEN         441
FT                   /note="F->W,Y: No effect on activation of potassium efflux
FT                   by glutathione adducts."
FT                   /evidence="ECO:0000269|PubMed:21041667"
FT   MUTAGEN         499
FT                   /note="D->A: Strongly reduced activation of potassium
FT                   efflux by glutathione adducts."
FT                   /evidence="ECO:0000269|PubMed:21041667"
FT   MUTAGEN         499
FT                   /note="D->G: Mildly reduced activation of potassium efflux
FT                   by glutathione adducts."
FT                   /evidence="ECO:0000269|PubMed:21041667"
FT   MUTAGEN         499
FT                   /note="D->S: No effect on potassium efflux."
FT                   /evidence="ECO:0000269|PubMed:21041667"
FT   MUTAGEN         516
FT                   /note="R->A: Increases constitutive potassium efflux and
FT                   abolishes regulation of potassium efflux by glutathione and
FT                   glutathione adducts; when associated with A-416 and A-551."
FT                   /evidence="ECO:0000269|PubMed:21041667"
FT   MUTAGEN         520
FT                   /note="E->G: Strongly reduced potassium efflux."
FT                   /evidence="ECO:0000269|PubMed:19523906"
FT   MUTAGEN         522
FT                   /note="A->V: Strongly reduced potassium efflux."
FT                   /evidence="ECO:0000269|PubMed:19523906"
FT   MUTAGEN         526
FT                   /note="G->V: Strongly reduced potassium efflux."
FT                   /evidence="ECO:0000269|PubMed:19523906"
FT   MUTAGEN         551
FT                   /note="N->A: Increases constitutive potassium efflux and
FT                   abolishes regulation of potassium efflux by glutathione and
FT                   glutathione adducts; when associated with A-416 and A-516."
FT                   /evidence="ECO:0000269|PubMed:19523906,
FT                   ECO:0000269|PubMed:21041667"
FT   MUTAGEN         551
FT                   /note="N->D: Increases constitutive potassium efflux; when
FT                   associated with K-262."
FT                   /evidence="ECO:0000269|PubMed:19523906,
FT                   ECO:0000269|PubMed:21041667"
FT   STRAND          401..405
FT                   /evidence="ECO:0007829|PDB:3L9W"
FT   HELIX           409..420
FT                   /evidence="ECO:0007829|PDB:3L9W"
FT   STRAND          425..429
FT                   /evidence="ECO:0007829|PDB:3L9W"
FT   HELIX           432..440
FT                   /evidence="ECO:0007829|PDB:3L9W"
FT   STRAND          446..448
FT                   /evidence="ECO:0007829|PDB:3L9W"
FT   HELIX           453..458
FT                   /evidence="ECO:0007829|PDB:3L9W"
FT   TURN            459..463
FT                   /evidence="ECO:0007829|PDB:3L9W"
FT   STRAND          465..469
FT                   /evidence="ECO:0007829|PDB:3L9W"
FT   HELIX           474..487
FT                   /evidence="ECO:0007829|PDB:3L9W"
FT   STRAND          492..499
FT                   /evidence="ECO:0007829|PDB:3L9W"
FT   HELIX           500..508
FT                   /evidence="ECO:0007829|PDB:3L9W"
FT   HELIX           519..532
FT                   /evidence="ECO:0007829|PDB:3L9W"
FT   HELIX           537..560
FT                   /evidence="ECO:0007829|PDB:3L9W"
FT   HELIX           565..579
FT                   /evidence="ECO:0007829|PDB:3L9W"
SQ   SEQUENCE   620 AA;  67796 MW;  9995B2E8E3C1DCE3 CRC64;
     MDSHTLIQAL IYLGSAALIV PIAVRLGLGS VLGYLIAGCI IGPWGLRLVT DAESILHFAE
     IGVVLMLFII GLELDPQRLW KLRAAVFGCG ALQMVICGGL LGLFCMLLGL RWQVAELIGM
     TLALSSTAIA MQAMNERNLM VTQMGRSAFA VLLFQDIAAI PLVAMIPLLA TSSASTTMGA
     FALSALKVAG ALVLVVLLGR YVTRPALRFV ARSGLREVFS AVALFLVFGF GLLLEEVGLS
     MAMGAFLAGV LLASSEYRHA LESDIEPFKG LLLGLFFIGV GMSIDFGTLL ENPLRIVILL
     LGFLIIKIAM LWLIARPLQV PNKQRRWFAV LLGQGSEFAF VVFGAAQMAN VLEPEWAKSL
     TLAVALSMAA TPILLVILNR LEQSSTEEAR EADEIDEEQP RVIIAGFGRF GQITGRLLLS
     SGVKMVVLDH DPDHIETLRK FGMKVFYGDA TRMDLLESAG AAKAEVLINA IDDPQTNLQL
     TEMVKEHFPH LQIIARARDV DHYIRLRQAG VEKPERETFE GALKTGRLAL ESLGLGPYEA
     RERADVFRRF NIQMVEEMAM VENDTKARAA VYKRTSAMLS EIITEDREHL SLIQRHGWQG
     TEEGKHTGNM ADEPETKPSS
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024